The benefits and harms of screening for cancer with a focus on breast screening

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 3, 2010, Pages 89-94

  Brodersen, John ^a   Jørgensen, Karsten J ^b   Gøtzsche, Peter C ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

Benefits; Breast cancer; Harms; Informed consent; Screening

Indexed keywords

BREAST CANCER; BREAST SELF EXAMINATION; CANCER MORTALITY; CANCER SCREENING; FALSE POSITIVE RESULT; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL STRESS; THERMOGRAPHY; ULTRASOUND;

EID: 77950964361     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.895     Document Type: Review

References (42)

1. Welch HG. Should I be tested for cancer? Maybe not and here's why. Los Angeles, California: University of California Press; 2004.
2. Gray JA. Evidence-based healthcare: how to make health policy and management decisions. London: Churchill Livingstone; 1997.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333.
4. Veronesi U, Boyle P, Goldhirsch A, et al. Breast cancer. Lancet. 2005; 365: 1727-1741.
5. Dano H, Andersen O, Ewertz M, et al. Socioeconomic status and breast cancer in Denmark. Int J Epidemiol. 2003; 32: 218-224. (Pubitemid 36622266)
6. Dano H, Hansen KD, Jensen P, et al. Fertility pattern does not explain social gradient in breast cancer in Denmark. Int J Cancer. 2004; 111: 451-456. (Pubitemid 38998829)
7. Lightfoot N, Steggles S, Wilkinson D, et al. The short-term psychological impact of organised breast cancer screening. Curr Oncol. 1994; 1: 206-211.
8. Ideström M, Milsom I, Andersson-Ellström A, Athlin E. Cervical cancer screening - "For better or worse...": women's experience of screening. Cancer Nurs. 2006; 29: 453-460.
9. Lynge E. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group. APMIS 1998; APMIS Suppl. 1998; 83: 1-44.
10. Webster P, Austoker J. Women's knowledge about breast cancer risk and their views of the purpose and implications of breast screening - a questionnaire survey. J Public Health (Oxf). 2006; 28: 197-202. (Pubitemid 44418596)
11. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009; 360: 1320-1328.
12. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993; 12: 186-192.
13. Ottesen GL, Graversen HP, Blichert-Toft M, et al. Carcinoma in situ of the female breast 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197-210.
14. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002; 94: 1546-1554. (Pubitemid 35277278)
15. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998; 16: 1265-1269. (Pubitemid 28175738)
16. Zahl PH, Maehlen J, Welch HG. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med. 2008; 168: 2311-2316.
17. Lindgren A, Holmberg L, Thurfjell E. The influence of mammography screening on the pathological panorama of breast cancer. APMIS. 1997; 105: 62-70. (Pubitemid 27504558)
18. Poller DN. Pathology of ductal carcinoma in situ of the breast: current status. Eur J Surg Oncol. 2001; 27: 498-503. (Pubitemid 32694606)
19. Brodersen J, Thorsen H, Cockburn J. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen. 2004; 11: 39-44. (Pubitemid 38365694)
20. Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health. 2007; 10: 294-304. (Pubitemid 47077254)
21. Brodersen J, Thorsen H. Consequences of Screening in Breast Cancer (COS-BC): development of a questionnaire. Scand J Prim Health Care. 2008; 26: 251-256.
22. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med. 2001; 23: 292-300. (Pubitemid 34087292)
23. Brodersen J. Measuring psychosocial consequences of false-positive screening results - breast cancer as an example. Department of General Practice, Institute of Public Health, Faculty of Health Sciences, University of Copenhagen: Månedsskrift for Praktisk Lægegerning, Copenhagen. ISBN: 87-88638-36-7; 2006.
24. Fox MS. On the diagnosis and treatment of breast cancer. JAMA. 1979; 241: 489-494.
25. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 1981; 66: 1191-1308. (Pubitemid 11063920)
26. Janzon L, Andersson I. The Malmö mammographic screening trial. Cambridge, United Kingdom: Cambridge University Press; 1991: 37-44.
27. Moody-Ayers SY, Wells CK, Feinstein AR. "Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000; 160: 1109-1115.
28. Mammografiscreeningen i Fyns Arnt 1993-1997. En medicinsk teknologivurdering. 2004. CEMTV. Ref Type: Report. http://www.sst.dk/publ/ Publ2004/CEMTV-mammo-fyn.pdf. Accessed December 15, 2009.
29. Vainio H, Bianchini F. IARC Handbooks of Cancer Prevention. Vol 7. Breast Cancer Screening, Screening techniques: 28. Lyon, France: IARC Press; 2002. http://www.iarc.fr/en/publications/pdfs-online/prev/handbook7/ Handbook7-Breast-0.pdf. Accessed December 15, 2009.
30. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000; 20; 355: 1757-1770.
31. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2009; CD001 877.
32. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programs: systematic review of incidence trends. BMJ. 2009; 339: b2587.
33. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009; 151: 727-742.
34. Kosters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev. 2003; (2): CD003 373.
35. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75-89. (Pubitemid 46535708)
36. Slaytor EK, Ward JE. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets (see comments). BMJ. 1998; 317: 263-264.
37. Jørgensen KJ, Gøtzsche PC. Content of invitations for publicly funded screening mammography. BMJ. 2006; 332: 538-541.
38. Jørgensen KJ, Gøtzsche PC. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ. 2004; 328: 148-153.
39. Jørgensen KJ, Klahn A, Gøtzsche PC. Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med. 2007; 5: 12.
40. Osterlie W, Solbjor M, Skolbekken JA, et al. Challenges of informed choice in organised screening. J Med Ethics. 2008; 34: e5.
41. Gøtzsche PC, Harding OJ, Nielsen M, et al. Breast screening: the facts - or maybe not. BMJ. 2009; 338: 446-448.
42. Baum M, McCartney M, Thornton H, et al. Breast cancer screening peril: negative consequences of the breast screening program. Times Online. http://www.timesonline.co.uk/tol/comment/letters/article5761650.ece. Published February 15, 2009. Accessed December 15, 2009.